AI Article Synopsis
Article Abstract
Background: Host cell microRNAs (miRNAs) have been shown to regulate the expression of both cellular and viral RNAs, in particular impacting both Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV). To investigate the role of miRNAs in regulating replication of the simian immunodeficiency virus (SIV) in macrophage lineage cells, we used primary macrophages to study targeting of SIV RNA by miRNAs. We examined whether specific host miRNAs directly target SIV RNA early in infection and might be induced via type I interferon pathways.
Results: miRNA target prediction programs identified miRNA binding sites within SIV RNA. Predicted binding sites for miRs-29a, -29b, -9 and -146a were identified in the SIV Nef/U3 and R regions, and all four miRNAs decreased virus production and viral RNA expression in primary macrophages. To determine whether levels of these miRNAs were affected by SIV infection, IFNβ or TNFα treatments, miRNA RT-qPCR assays measured miRNA levels after infection or treatment of macrophages. SIV RNA levels as well as virus production was downregulated by direct targeting of the SIV Nef/U3 and R regions by four miRNAs. miRs-29a, -29b, -9 and -146a were induced in primary macrophages after SIV infection. Each of these miRNAs was regulated by innate immune signaling through TNFα and/or the type I IFN, IFNβ.
Conclusions: The effects on miRNAs caused by HIV/SIV infection are illustrated by changes in their cellular expression throughout the course of disease, and in different patient populations. Our data demonstrate that levels of primary transcripts and mature miRs-29a, -29b, -9 and -146a are modulated by SIV infection. We show that the SIV 3' UTR contains functional miRNA response elements (MREs) for all four miRNAs. Notably, these miRNAs regulate virus production and viral RNA levels in macrophages, the primary cells infected in the CNS that drive inflammation leading to HIV-associated neurocognitive disorders. This report may aid in identification miRNAs that target viral RNAs and HIV/SIV specifically, as well as in identification of miRNAs that may be targets of new therapies to treat HIV.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766675 | PMC |
| http://dx.doi.org/10.1186/1742-4690-10-95 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The quality of SIV-specific fCD8 T cells limits SIV RNA production in Tfh cells during antiretroviral therapy.
J Virol
December 2024
Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
Article Synopsis
- * It finds that the frequency of SIV-Gag-specific follicular CD8 T cells is linked to the amount of SIV-RNA, particularly in treated or naturally controlling macaques, while showing a different behavior in untreated macaques.
- * The research indicates that the gene expression profile of fCD8 T cells in naturally controlled infections is more favorable compared to those under cART, suggesting that improving these cells may lead to potential curative strategies for HIV/SIV.
A molecular and immunohistochemical study of 37 cases of ovarian Sertoli-Leydig cell tumor.
Virchows Arch
November 2024
Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Article Synopsis
- This study analyzes 37 ovarian Sertoli-Leydig cell tumors (SLCT) with a focus on their morphology, immunohistochemistry, and molecular features, categorizing them into well, moderately, and poorly differentiated tumors.
- High levels of sex cord markers were found, along with variable expression of other markers, and notable mutations like DICER1 (54.5%) and FOXL2 (6%) were identified, suggesting important diagnostic and predictive implications.
- Differences in mRNA expression profiles between DICER1 and non-DICER1 tumors highlight the distinct molecular characteristics of SLCTs, indicating that well-differentiated tumors could represent a unique subtype apart from the others.
Sivelestat protects against acute lung injury by up-regulating angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptors.
J Thorac Dis
September 2024
Department of Respiratory Medicine, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Article Synopsis
- Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) have high mortality rates, especially as complications of severe COVID-19, and Sivelestat (SIV) is currently the only licensed treatment for these conditions.
- This study examines how SIV may help reduce LPS-induced ALI by preventing the down-regulation of the ACE2/Ang-(1-7)/Mas receptor pathway, which is important for lung health.
- Results showed that rats treated with SIV or dexamethasone had lower lung damage and inflammation levels compared to those only treated with LPS, indicating that SIV could help protect against ALI.
Article Synopsis
- Epitranscriptomic modifications, like N6-methyladenosine (m6A) methylation, play a key role in regulating gene expression and have implications in diseases such as cancer and inflammation.
- In this study, researchers found that m6A modifications in miRNAs from the brains of Rhesus Monkeys vary based on whether they were uninfected or infected with SIV and treated with anti-retroviral therapy or THC:CBD.
- The findings suggest that THC:CBD treatments lower m6A methylation in specific miRNAs that target proinflammatory genes, potentially explaining beneficial effects on neuroinflammation in diseases such as Alzheimer’s and Parkinson’s.
Evolutionary diversity of CXCL16-CXCR6: Convergent substitutions and recurrent gene loss in sauropsids.
Immunogenetics
December 2024
Computational Evolutionary Genomics Lab, Department of Biological Sciences, IISER Bhopal, Bhauri, Madhya Pradesh, India.
The CXCL16-CXCR6 axis is crucial for regulating the persistence of CD8 tissue-resident memory T cells (T). CXCR6 deficiency lowers T cell numbers in the lungs and depletes ILC3s in the lamina propria, impairing mucosal defence. This axis is linked to diseases like HIV/SIV, cancer, and COVID-19.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!